Journey Medical Free Cash Flow (FCF) History (DERM)
Journey Medical reported −$24.1M in free cash flow for fiscal 2024, a decrease of $24.4M from the previous fiscal year, with a free cash flow margin of −43.76%.
View full Journey Medical company overviewJourney Medical free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$24.1M | −$24.4M | — | −43.76% |
| 2023 | 2023-12-31 | $240,000 | $33.8M | — | +0.40% |
| 2022 | 2022-12-31 | −$33.5M | — | — | −47.23% |
Journey Medical quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$16.5M | −$12.7M | — | −108.28% |
| Q3 2023 | 2023-09-30 | $18.7M | $26.0M | — | +122.70% |
| Q2 2023 | 2023-06-30 | $4.0M | $7.3M | — | +23.40% |
| Q1 2023 | 2023-03-31 | −$6.0M | $13.2M | — | −48.96% |
| Q4 2022 | 2022-12-31 | −$3.8M | — | — | −24.09% |
| Q3 2022 | 2022-09-30 | −$7.3M | — | — | −45.39% |
| Q2 2022 | 2022-06-30 | −$3.3M | — | — | −18.10% |
| Q1 2022 | 2022-03-31 | −$19.1M | — | — | −91.92% |
Journey Medical free cash flow growth trends
Journey Medical's latest reported quarter, Q4 2023, generated −$16.5M in free cash flow, a decrease of $12.7M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Journey Medical filings at SEC.gov ↗